Mustafa Özdoğan, MD· @ozdogan_md · X·· 4 小时前评分70
正文 · 原文
dMMR endometrial cancer: do we still need chemo upfront?
#ESMO26 KEYNOTE-C93: pembrolizumab alone delays progression longer, with far less toxicity. Survival still unclear.
New default?
Dr Brian Slomovitz
#EndometrialCancer
79 浏览 · 0 赞 · 0 转发 · 0 回复
来源：Mustafa Özdoğan, MD · x.com